CYP2D6 genetic polymorphism in South Indian populations

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 8, 2006, Pages 1655-1658

  Naveen, Amrithraj Theophilus ^a   Adithan, Chandrasekaran ^a   Soya, Sisy Sam ^a   Gerard, Nathalie ^b   Krishnamoorthy, Rajagopal ^b  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Allele frequency; CYP2D6; Genotype; Polymorphism; South Indians

Indexed keywords

CYTOCHROME P450 2D6; DRUG METABOLIZING ENZYME;

ADULT; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; NORMAL HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; BASE SEQUENCE; CYTOCHROME P-450 CYP2D6; DNA PRIMERS; HUMANS; INDIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 33746732279     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1655     Document Type: Article

References (19)

1. Ingelman-Sundberg M., Pharmacogenomics J., 5, 6-13 (2005).
2. Kubota T., Yamaura Y., Ohkawa N., Hara H., Chiba K., Br. J. Clin. Pharmacol., 50, 31-34 (2000).
3. Gaedigk A., DiAnne Bradford L., Marcucci Kenda A., Leeder J. S., Clin. Pharmacol. Ther., 72, 76-89 (2002).
4. Kirchheiner J., Brosen K., Dahl M. L., Gram L. F., Kasper S., Roots I., Sjoqvist F., Spina E., Brockmoller J., Acta Psychiatr. Scand., 104, 173-192 (2001).
5. Guzey C., Spigset O., Curr. Top. Med. Chem., 4, 1411-1421 (2004).
6. Adithan C., Gerard N., Naveen A. T., Koumaravelou K., Shashindran C. H., Krishnamoorthy R., Eur. J. Clin. Pharmacol., 59, 517-520 (2003).
7. Daly A. K., Brockmoller J., Broly F., Eichelbaum M., Evans W. E., Gonzalez E. J., Huang J. D., Idle J. R., Ingelman-Sundberg M., Ishizaki T., Jacqz-Aigrain E., Meyer U. A., Nebert D. W., Steen V. M., Wolf C. R., Zanger U. M., Pharmacogenetics, 6, 193-201 (1996).
8. Masimirembwa C., Persson I., Bertilsson L., Hasler J., Ingelman-Sundberg M., Br. J. Clin. Pharmacol., 42, 713-719 (1996).
9. Sachse C., Brockmoller J., Bauer S., Roots I., Am. J. Hum. Genet., 60, 284-295 (1997).
10. Gough A. C., Miles J. S., Spurr N. K., Moss J. E., Gaedigk A., Eichelbaum M., Wolf C. R., Nature (London), 347, 773-776 (1990).
11. Steen V. M., Andreassen O. A., Daly A. K., Tefre T., Borresen A. L., Idle J. R., Gulbrandsen A. K., Pharmacogenetics, 5, 215-223 (1995).
12. Buch S., Kotekar A., Kawle D., Bhisey R., Eur. J. Clin. Pharmacol., 57, 553-555 (2001).
13. Abraham B. K., Adithan C., Mohanasundaram J., Shashindran C. H., Koumaravelou K., Asad M., Eur. J. Clin. Pharmacol., 56, 849-850 (2001).
14. Abraham B. K., Adithan C., Shashindran C. H., Vasu S., Alekutty N. A., Br. J. Clin. Pharmacol., 49, 285-286 (2000).
15. Abraham B. K., Adithan C., Kiran P. U., Asad M., Koumaravelou K., Acta Pharmacol. Sin., 21, 494-498 (2000).
16. Raimundo S., Toscano C., Klein K., Fischer J., Griese E. U., Eichelbaum M., Schwab M., Zanger U. M., Clin. Pharmacol. Ther., 76, 128-138 (2004).
17. Ikenaga Y., Fukuda T., Fukuda K., Nishida Y., Naohara M., Maune H., Azuma J., Drug Metab. Pharmacokinet., 20, 113-116 (2005).
18. Hersberger M., Marti-Juan J., Rentsch K., Hanseler E., Clin. Chem., 46, 1072-1077 (2000).
19. Ji L., Pan S., Marti-Juan J., Hanseler E., Rentsch K., Hersberger M., Clin. Chem., 48, 983-988 (2002).